NCT05734222

Brief Summary

The goal of our work of optimization of the treatment of postoperative hernias is to improve the results of treatment of patients with median and median-lateral postoperative hernias of medium (W2) and large (W3) sizes by developing new surgical techniques. The main questions it aims to answer are:

  1. 1.To study the topographic and variant anatomy of vessels and nerves in the retromuscular, preperitoneal, postperitoneal and pre-abdominal cell spaces of the anterior abdominal wall. To determine the most probable sources of blood flow and lymph from the anatomical formations forming the bed of the endoprosthesis.
  2. 2.To develop technical, surgical techniques that allow to form an implant bed with minimal traumatization of blood vessels and nerves and reduce the risk of postoperative complications.
  3. 3.To develop a technique for plasty of the anterior abdominal wall in mid-lateral postoperative hernias with a combination of retromuscular and subaponeurotic spaces.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 29, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 8, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 17, 2023

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
23 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 23, 2025

Completed
Last Updated

January 1, 2025

Status Verified

December 1, 2024

Enrollment Period

2.6 years

First QC Date

February 8, 2023

Last Update Submit

December 31, 2024

Conditions

Keywords

Herniamedianmedian-lateralmedian-lateral Incisional herniaIncisional

Outcome Measures

Primary Outcomes (3)

  • rate of seroma

    rate of development of seroma in postoperative area

    5 days

  • rate of hematoma

    rate of development of hematoma in postoperative area

    5 days

  • Recurrence rate

    Rate of hernia recurrences diagnosed at clinical and/or ultrasound examination

    One year

Secondary Outcomes (2)

  • Pus

    7 days

  • Persisting postoperative pain

    one year

Study Arms (2)

Control Group

ACTIVE COMPARATOR

The control group is retrospective. It will include patients who have been operated on for POVG in the surgical department No. 1 of the KPH during the last 3 years (25-35) and 5-10 patients who will be operated on within the next 6-8 months.

Procedure: A new method of repair of the abdominal wall of mid-lateral postoperative ventral hernias

Established group

EXPERIMENTAL

The established group - patients who will be operated on in the surgical department No. 1 of the KPH over the next 1.5 - 2 years, using the developed techniques.

Procedure: A new method of repair of the abdominal wall of mid-lateral postoperative ventral hernias

Interventions

1. It is planned to study potential sources of bleeding and hematoma formation during SRM plastic surgery. On this basis, recommendations on the technique of the operation will be formulated. 2. It is supposed to find a way to preserve intercostal neurovascular bundles when performing SRM repair. This should improve the quality of abdominal wall reconstruction by preserving neurovascular bundles of muscles and reducing neuroalgic pain syndrome. 3. It is proposed to develop a method for combining retromuscular and subaponeurotic spaces in the treatment of mid-lateral hernias 4. It is planned to substantiate the effectiveness and expediency of the application of the developed surgical techniques based on the analysis of the immediate and long-term results of treatment.

Also known as: Development of techniques to minimize traumatization of the neurovascular bundles of the abdominal wall and reduce postoperative complications.
Control GroupEstablished group

Eligibility Criteria

Age25 Years - 88 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The study will include patients with postoperative ventral hernias of median and lateral localization and an average hernial gate width from 4.1 to 15 cm (W2-W3 according to the EHS classification).. The size of the hernial gate is determined by CT.

You may not qualify if:

  • Patients without postoperative ventral hernias median and lateral localization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinics of Samara State Medical University

Samara, Russia

RECRUITING

Related Publications (10)

  • Novitsky YW, Elliott HL, Orenstein SB, Rosen MJ. Transversus abdominis muscle release: a novel approach to posterior component separation during complex abdominal wall reconstruction. Am J Surg. 2012 Nov;204(5):709-16. doi: 10.1016/j.amjsurg.2012.02.008. Epub 2012 May 16.

  • Nielsen MF, de Beaux A, Stutchfield B, Kung J, Wigmore SJ, Tulloh B. Peritoneal flap hernioplasty for repair of incisional hernias after orthotopic liver transplantation. Hernia. 2022 Apr;26(2):481-487. doi: 10.1007/s10029-021-02409-5. Epub 2021 Apr 22.

  • Nielsen MF, de Beaux A, Damaskos D, Tulloh B. Peritoneal flap hernioplasty for reconstruction of transverse incisional hernias. Hernia. 2021 Apr;25(2):313-319. doi: 10.1007/s10029-019-02099-0. Epub 2019 Dec 7.

  • Kostov S, Dineva S, Kornovski Y, Slavchev S, Ivanova Y, Yordanov A. Vascular Anatomy and Variations of the Anterior Abdominal Wall - Significance in Abdominal Surgery. Prague Med Rep. 2023;124(2):108-142. doi: 10.14712/23362936.2023.9.

  • Oprea V, Radu VG, Moga D; -. Transversus Abdominis Muscle Release (TAR) for Large Incisional Hernia Repair. Chirurgia (Bucur). 2016 Nov-Dec;111(6):535-540. doi: 10.21614/chirurgia.111.6.535.

  • Клинические рекомендации "Послеоперационная вентральная грыжа", 2021-2022-2023 (23.10.2021) - Утверждены Минздравом РФ, ID 685 Doi 10.7602/jmis.2018.21.1.5

    RESULT
  • Диссертационное исследование Гуляев М.Г. "Профилактика и лечение рецидивных вен-тральных грыж после аутопластических и протезирующих вмешательств" 2015г/ Doi 10.17116/hirurgia201910136

    RESULT
  • Belokonev Vladimir, Sergey Pushkin, Zinaida Kovaleva, Yuliya Ponomareva, and Maksim Gulyaev. Etiology, Pathogenesis and Treatment of Recurrent Postoperative Ventral Hernias. INFRA-M Academic Publishing LLC., 2021. https://doi.org/10.12737/1058965.

    RESULT
  • Мадьяров, В.М., Р.Б. Турсунов, С.П. Мухаметова, and М.Е. Кусманов. "Prevention of the risk of postoperative ventral hernias with open surgical interventions on the anterior ab-dominal wall." Vestnik, no. 4 (February 25, 2022): 98-104. https://doi.org/10.53065/kaznmu.2021.45.79.019.

    RESULT
  • Мишкин, И., I. Mishkin, Н. Садыкова, and N. Sadykova. "Comparative characteristics of tension free techniques hernioplasty in the treatment of ventral hernias." Clinical Medicine and Pharmacology 4, no. 2 (July 27, 2018): 27-30. https://doi.org/10.12737/article_5b5ade394350a0.50327344.

    RESULT

MeSH Terms

Conditions

Hernia, VentralHernia, AbdominalHerniaSurgical Wound

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsWounds and Injuries

Study Officials

  • Vladislav Timoschuk, Phd Student

    Samara State Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alexander Sonis, doctor

CONTACT

Vladislav Timoschuk, PhD student

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
4\. The comparison groups will include patients who underwent retromuscular plastic surgery followed by aspiration drainage of the prosthesis bed. When analyzing the results, the presence of obesity and coagulopathy will be taken into account, CT and ultrasound examination will be carried out. Special attention will be paid to the presence and volume of liquid formations in the implant bed. 5\. Immediate results will be evaluated up to 1 year Criteria for evaluating immediate results: treatment time, pain syndrome, the presence of seromas and hematomas, their infection and suppuration. 6\. Long-term results will be evaluated in terms from 1 to 1.5 years. Evaluation criteria: the presence of recurrent hernia, the presence of late complications - fistulas, seromas requiring drainage, pain syndrome.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: The study will include patients with postoperative ventral hernias of median and lateral localization and an average hernial gate width from 4.1 to 15 cm (W2-W3 according to the EHS classification).. The size of the hernial gate is determined by CT. The estimated number of patients is 60-80. 25-30 patients with median-lateral ventral postoperative hernias and 35-50 patients with median hernias are expected. 2\. The control group is retrospective. It will include patients who have been operated on for POVG in the surgical department No. 1 of the KPH during the last 3 years (25-35) and 5-10 patients who will be operated on within the next 6-8 months. 3\. The established group - patients who will be operated on in the surgical department No. 1 of the KPH over the next 1.5 - 2 years, using the developed techniques.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 8, 2023

First Posted

February 17, 2023

Study Start

September 29, 2022

Primary Completion

April 30, 2025

Study Completion

May 23, 2025

Last Updated

January 1, 2025

Record last verified: 2024-12

Locations